Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2010
07/01/2010US20100167386 Immunosensor system for blood with reduced interference
07/01/2010US20100167385 User interface features for an electronic device
07/01/2010US20100167384 Microfluidic mixing and analytical apparatus
07/01/2010US20100167355 Microreactor with vent channels for removing air from a reaction chamber
07/01/2010US20100167348 Peptide capable of binding to immunoglobulin
07/01/2010US20100167340 Method to produce a receptor chip using biotinylated protein
07/01/2010US20100167333 Heavy Metal Binding Compounds and Their Method of Use
07/01/2010US20100167326 Method for cleavage of peptidic bond at c terminal of peptide and a method for determination of c terminal amino acid sequence of peptide
07/01/2010US20100167325 Methods for detecting risk of fatal prostate cancer using serum calcium
07/01/2010US20100167324 Quantitative Assays for Ras p21 in Body Fluids
07/01/2010US20100167323 stabilizing one or more analytes in solutions for a denaturing immunoassay of body samples; solubilizing, denaturing, heating, stabilizing and storing; human papilloma virus
07/01/2010US20100167322 Method of detecting cerebral stroke or asymptomatic cerebral infarction using acrolein, interleukin-6 and crp contents, polyamine oxidase activity or polyamine oxidase protein content and subject's age as indicators
07/01/2010US20100167321 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
07/01/2010US20100167320 Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States
07/01/2010US20100167319 Diagnose of Mycobacterial Infections by Determination of IFN-Gamma
07/01/2010US20100167318 Fluidic Structures Including Meandering and Wide Channels
07/01/2010US20100167317 Process for enriching basophils in a blood sample
07/01/2010US20100167316 Enrichment of Tissue-Derived Adult Stem Cells Based on Retained Extracellular Matrix Material
07/01/2010US20100167315 Method for investigating the response to a treatment with a monoclonal antibody
07/01/2010US20100167314 Control of intracellular target molecule by ip3 receptor-binding protein
07/01/2010US20100167313 Anti-idiotype antibody against an antibody against the amyloid beta peptide
07/01/2010US20100167312 Method for assaying a target analyte while reducing interference in an immunosensor system
07/01/2010US20100167311 Oxidoreductases and Processes Utilising Such Enzymes
07/01/2010US20100167310 Reagent for Measuring Agglutination and Method of Measuring Agglutination
07/01/2010US20100167309 Apparatus and method for analyte detection
07/01/2010US20100167308 Method for measuring an analyte in blood
07/01/2010US20100167307 Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays
07/01/2010US20100167306 Rapid test for glycated albumin in saliva
07/01/2010US20100167297 Method of determining the time to progression of non small cell lung cancer after chemotherapy based on thioredoxin expression
07/01/2010US20100167293 Digital Assay
07/01/2010US20100167290 Molecule attachment to nanoparticles
07/01/2010US20100167286 Pluripotent cell lines and methods of use thereof
07/01/2010US20100167278 Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer
07/01/2010US20100167275 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels
07/01/2010US20100167264 Quantitative analyte assay device and method
07/01/2010US20100167263 Novel biosensor system based on recognition induced birefringence (rib)
07/01/2010US20100167262 Method and reagent for the specific identification and quantification of one or more proteins in a sample using in particular inductively coupled plasma-mass spectrometry
07/01/2010US20100166800 Recombinant attenuated clostridium organisms and vaccine
07/01/2010US20100166792 Antigenic Polypeptides
07/01/2010US20100166789 Proteins for use in diagnosing and treating infection and disease
07/01/2010US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof
07/01/2010US20100166775 S100a9 interaction screening method
07/01/2010US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx
07/01/2010US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles
07/01/2010US20100166763 Method for determining the immunogenicity of an antigen
07/01/2010US20100166761 Compositions and methods for the treatment of immune related diseases
07/01/2010US20100166759 Metallothionein-Derived Peptide Fragments
07/01/2010US20100166739 Methods and Compositions for Diagnosing Urological Disorders
07/01/2010US20100166732 Small streptococcus pyogenes antigens and their use
07/01/2010US20100166724 Uses of thioredoxin
07/01/2010US20100166714 Cardiovascular stem cells, methods for stem cell isolation, and uses thereof
07/01/2010US20100166702 Alkylated interleukin-18 and related compositions, kits, and methods of making and using same
07/01/2010US20100166694 Diagnostic markers of wound infection
07/01/2010US20100166658 Monkey homolog of human oncostatin m
07/01/2010US20100166657 USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER
07/01/2010US20100166652 Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody
07/01/2010US20100166607 Printable hydrogels for biosensors
07/01/2010US20100165325 Optical system for a particle analyzer and particle analyzer using same
07/01/2010US20100165324 Raman spectroscopic monitoring of hemodialysis
07/01/2010US20100163806 Tunable Fluorescent Gold Nanocluster And Method for forming the same
07/01/2010US20100163800 Monodisperse Core/Shell and Other Complex Structured Nanocrystals and Methods of Preparing the Same
07/01/2010US20100163720 Means and method for diagnosing diabetes
07/01/2010US20100163461 Method and system for controlling the amount of anti-fouling additive for particulate-induced fouling mitigation in refining operations
07/01/2010US20100163432 Microsensor for detection of d-amino-acids
07/01/2010US20100163431 Sensor
07/01/2010US20100163034 Methods and systems for presenting an inhalation experience
07/01/2010US20100162786 System and/or method for glucose sensor calibration
07/01/2010DE202009006373U1 Sondenträger zur Ermittlung, Kontrolle und Datenerfassung in Feuerungsanlagen, in schwer zugängigen Räumen, Hohlräumen und Behältern, Kurzbezeichnung Sondenträger Probe carrier to identify, control and data acquisition in furnaces, in hardly accessible spaces, cavities and containers abbreviation probe carrier
07/01/2010DE102008064164A1 Verfahren zur räumlich hochauflösenden stochastischen Untersuchung einer mit einer Substanz markierten Struktur einer Probe Method for high spatial resolution stochastic examination of labeled with a substance of a sample
07/01/2010DE102007047093B4 Vorrichtung zur Messung von Fluoreszenzstrahlung an biologischen Substanzen mit einer Halbleitersensorenanordnung Device for measuring fluorescent radiation of organic substances with a semiconductor sensor arrangement
07/01/2010CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
07/01/2010CA2748364A1 Method for pretreating specimen and method for assaying biological substance
07/01/2010CA2748258A1 Control system for monitoring localized corrosion in an industrial water system
07/01/2010CA2748157A1 Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
07/01/2010CA2747953A1 Recombinant von willibrand factor as a molecular weight marker for mass spectrometry analyses
07/01/2010CA2747942A1 Armet as a marker for cancer
07/01/2010CA2747937A1 Biomarkers for inhibitors with anti-angiogenic activity
07/01/2010CA2747418A1 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents
07/01/2010CA2746942A1 Ex-vivo passive protection bacteremia assay
07/01/2010CA2746452A1 Methods of detection of changes in cells
07/01/2010CA2746120A1 Methods and compositions for diagnostic use in cancer patients
07/01/2010CA2745580A1 Assay device and method for performing biological assays
07/01/2010CA2745371A1 Methods, reagents and kits for the identification of modulators of voltage-gated sodium channels
07/01/2010CA2745189A1 Methods for detection of sepsis
06/2010
06/30/2010EP2202660A1 System and method for consensus-calling with per-base quality values for sample assemblies
06/30/2010EP2202522A1 Methods for immobilizing microvesicles, means and methods for detecting them, and uses thereof
06/30/2010EP2202521A1 Surface chemical modification of optical elements for the spectroscopic detection of molecules and organic components
06/30/2010EP2202520A1 Clinically intelligent diagnostic devices and methods
06/30/2010EP2202519A1 A detector system for identifying substances in a sample
06/30/2010EP2202518A1 In vivo assay for quantifying clostridial neurotoxin activity
06/30/2010EP2202517A1 A cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid,a corresponding measuring system, and a corresponding method
06/30/2010EP2202516A1 Reagent kit for sample analysis and sample analysis method
06/30/2010EP2202515A2 Method For Predicting Petroleum Expulsion
06/30/2010EP2202514A2 Method For Predicting Composition Of Petroleum
06/30/2010EP2202511A2 Quantitative analyzing method and quantitative analyzer using sensor
06/30/2010EP2202321A1 Evaluation of the potential risk of drug induced mood disturbance and suicide:use of a dedicated platform
06/30/2010EP2202319A1 Nucleic acid probe, and method for production of probe polymer
06/30/2010EP2202308A2 Methods and compositions for polypeptide engineering
06/30/2010EP2202298A1 Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
06/30/2010EP2202295A1 Method for efficient production of monocyte-derived multipotent cell (momc)